Financhill
Back

Cogent Biosciences 10K Form

Sell
46

COGT
Cogent Biosciences

Last Price:
7.44
Seasonality Move:
-19.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive COGT News And Ratings

See the #1 stock for the next 7 days that we like better than COGT

COGT Financial Statistics

Sales & Book Value

Annual Sales: $7.87M
Cash Flow: $-38.09M
Price / Cash Flow: 0
Annual Sales: $2.12
Price / Book: 4.22

Profitability

EPS (TTM): -2.34000
Net Income (TTM): $-177.66M
Gross Margin: $72.86M
Return on Equity: 0%
Return on Assets: 0%

Cogent Biosciences Earnings Forecast

Key Cogent Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for COGT is 871.53%.
  • The Selling, General & Administrative Expenses for COGT have been equal to 221.34% of Gross Profit Margin.
  • Per Share Earnings over the last 10 years have been positive in 3 years.

Cogent Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: COGT
CUSIP: 19240Q
Website: cogentbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

COGT Technical Analysis vs Fundamental Analysis

Sell
46
Cogent Biosciences (COGT) is a Sell

Is Cogent Biosciences a Buy or a Sell?